RobertB.JaffeMD
Obstetrics & Gynecology • San Francisco, CAReproductive Endocrinology & Infertility
Professor, Obstetrics/Gynecology & Reproductive Science, UCSF School of Medicine
Are you Dr. Jaffe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2356 Sutter St
San Francisco, CA 94115Phone+1 415-476-6130Fax+1 415-476-0793
Summary
- Dr. Robert Jaffe, MD is an obstetrician/gynecologist in San Francisco, California. He is currently licensed to practice medicine in California. He is a Professor at UCSF School of Medicine.
Education & Training
University of ColoradoResidency, Obstetrics and Gynecology, 1959 - 1963- University of ColoradoResidency, Internal Medicine, 1958 - 1959
- University of Colorado School of MedicineInternship, Transitional Year, 1957 - 1958
University of Michigan Medical SchoolClass of 1957
Certifications & Licensure
CA State Medical License Active through 2014- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1985
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss Start of enrollment: 2002 May 01
Publications & Presentations
PubMed
- 37 citationsDll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor GrowthJie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton
Molecular Cancer Therapeutics. 2016-06-01 - 86 citationsBiological roles of the Delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancerWei Hu, Chunhua Lu, Han Hee Dong, Jie Huang, Deyu Shen
Cancer Research. 2011-09-15 - 61 citationsPhase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L. Coleman, Linda R. Duska, John V. Heymach, Aparna A. Kamat, Susan C. Modesitt
The Lancet. Oncology. 2011-11-01
Press Mentions
- Profiles in Ob/Gyn: A Pioneer in Preeclampsia ResearchApril 23rd, 2019
Celmatix Launches MyFertility Compass™ to Give Women Better Insights into Their Family Building JourneyJuly 10th, 2018
Prominent Physicians Join Juniper Pharmaceuticals' Scientific Advisory BoardJanuary 20th, 2016- Join now to see all
